Dextra Hedelmällisyysklinikka

What Dextra Hedelmällisyysklinikka does

Dextra Hedelmällisyysklinikka is a Finnish fertility clinic headquartered in Helsinki, founded in 2013 and operating as part of the Pihlajalinna Group. It delivers a comprehensive suite of assisted reproduction services including fertility investigations (semen analysis, AMH testing, tubal patency testing), ovulation induction, intrauterine insemination, IVF, ICSI, preimplantation genetic testing for aneuploidy (PGT-A), embryo freezing and storage, elective oocyte cryopreservation, donor gamete treatments (sperm, oocytes, embryos), recurrent miscarriage investigations, and pregnancy monitoring. The clinic performs approximately 70% of all Finland's PGT-A treatments according to THL statistics, positioning it as the leading embryo diagnostics provider in the Nordics. Underlying technology consists of standard modern assisted reproduction laboratory capabilities (IVF, ICSI, embryo culture and biopsy, PGT-A, ERA/BeReady endometrial receptivity testing, POC/niPOC chromosome studies) without proprietary AI or novel platform architecture disclosed.

The business operates a direct-to-consumer, fee-for-service revenue model with no physician referral required. Pricing is per-cycle: approximately €900 for basic investigations, ~€4,500 per IVF cycle, and ~€1,500 per frozen embryo transfer. Distribution runs through Pihlajalinnan's online booking portal, phone-based appointment scheduling, and in-clinic booking; clinical visits are also available via Pihlajalinna satellite locations in Lahti, Kouvola, and Lappeenranna. From 1 May 2025, Kela (Finnish Social Insurance Institution) reimburses fertility treatments, partially offsetting patient cost. Customer acquisition relies on paid social (Facebook, TikTok), Google Ads, organic social, content marketing, and educational fertility seminars. Quality and trust anchors include ISO 9001:2015 and ISO 14001:2015 certifications, the Key Flag Symbol, and a 91% customer recommendation rate per Value Clinic (May 2023).

Name

Dextra Hedelmällisyysklinikka

Legal name

Dextra Hedelmällisyysklinikka

Website

https://dextralapsettomuusklinikka.fi

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Dextra Hedelmällisyysklinikka is a Helsinki-based fertility clinic (founded 2013) operating within the Pihlajalinna Group, serving individuals and couples in Finland with IVF, ICSI, PGT-A embryo screening, donor gamete treatments, miscarriage investigations, and pregnancy monitoring. It performs approximately 70% of Finland's PGT-A procedures.

Ownership category

akta.pro rank

Product category

Fertility Clinic Services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)

Keywords

• Fertility clinic services
• Assisted reproduction treatments
• In vitro fertilization
• Embryo diagnostics
• Recurrent miscarriage care

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Fertility Treatment Services: Revenue is generated from fee-for-service fertility treatments and diagnostics. Services include initial consultations, fertility investigations (blood tests, semen analysis, tubal patency tests), ovulation induction, insemination, IVF, ICSI, embryo diagnostics (PGT-A), embryo freezing and storage, egg freezing, donor sperm and donor egg treatments, and pregnancy monitoring. Pricing is per treatment cycle or procedure.
2. Kela Reimbursement: From 1 May 2025, Kela (Finnish Social Insurance Institution) provides reimbursement for fertility treatments, which partially offsets costs for patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Dextra Hedelmällisyysklinikka is a private fertility clinic in Helsinki, Finland, offering comprehensive infertility investigations and assisted reproduction treatments. Services span fertility diagnostics (male and female), ovulation induction, intrauterine insemination (IUI), IVF with ICSI, embryo chromosome screening (PGT-A), egg and embryo freezing, donor gamete treatments, recurrent miscarriage investigations, and pregnancy monitoring — all delivered to individual patients and couples on a fee-for-service basis without requiring a doctor's referral.

Product overview

Dextra Hedelmällisyysklinikka is a fertility clinic offering a comprehensive suite of services under one umbrella. The core offering centers on infertility investigations and assisted reproduction treatments, progressing from basic interventions (ovulation induction, artificial insemination) to advanced IVF with ICSI and embryo diagnostics (PGT-A). The clinic operates specialized clinics for pregnancy monitoring and recurrent miscarriage management, and provides donor gamete treatments. All services are coordinated through an initial consultation that creates individualized treatment plans. The clinic performs approximately 70% of all PGT-A treatments in Finland, positioning it as a national leader in embryo diagnostics. Services are booked through Pihlajalinna's scheduling system as the parent company.

Differentiator

Problem solved

Functional benefit

Products and services

• Initial Consultation (Ensikäynti) First-visit appointment where a physician assesses the patient's situation, performs examinations, and creates an individualised fertility treatment plan. Available without a doctor's referral and offered with short waiting times.
• Infertility Investigations (Lapsettomuustutkimukset) Comprehensive fertility investigations including male fertility tests (semen analysis, DFI), female fertility tests (AMH measurement, tubal patency testing), and fertility mapping to identify causes of infertility in men and women.
• Ovulation Induction (Ovulaatioinduktiohoito) Fertility treatment that stimulates ovulation in women who do not ovulate regularly, often used as a first-line treatment for infertility.
• Artificial Insemination / IUI (Inseminaatio eli keinohedelmöitys) Artificial insemination (IUI) procedure in which sperm is placed directly into the uterus to facilitate fertilisation.
• In Vitro Fertilization (IVF / Koeputkihedelmöitys) In vitro fertilisation treatment cycle including egg retrieval, laboratory fertilisation, and embryo transfer, with associated services such as ICSI (microfertilisation), assisted hatching, extended embryo culture, and embryo freezing.
• Embryo Diagnostics / PGT-A (Alkiodiagnostiikka) Preimplantation genetic testing for aneuploidies (PGT-A) to screen embryos for chromosomal abnormalities, reducing the risk of miscarriage and failed IVF cycles.
• Pregnancy Clinic (Raskausklinikka) Pregnancy monitoring services including routine and early pregnancy ultrasound examinations (weeks 6–7), NIPT testing for chromosomal screening, and mental wellness support.
• Recurrent Miscarriage Clinic (Keskenmenoklinikka)

Quantifiable outcome

• 91% of customers recommend Dextra
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• PihlajalinnacoreStrategic or Co-development PartnerDextra is part of the Pihlajalinna Group. Pihlajalinna is the parent company providing operational infrastructure including its appointment booking platform, quality management systems (ISO 9001 and ISO 14001 certifications), customer feedback systems, and data privacy framework. Dextra directs patients to Pihlajalinnan's online booking system for scheduling appointments.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Others

• Genea: Australia-headquartered fertility clinic group and embryology technology developer (e.g., Geri incubator). Comparable to Dextra as an internationally operating fertility-services provider with proprietary embryology technology positions, relevant as a peer for clinical scale and innovation comparison.
• Vitrolife: Swedish-listed global supplier of IVF media, consumables, and time-lapse embryo incubation systems. Comparable to Dextra as a Nordic reproductive-medicine participant and a potential upstream supplier/partner for the clinic's IVF and PGT-A workflows.

Broad incumbents

• Pihlajalinna: Dextra's parent company and one of Finland's largest private healthcare groups, with primary care, specialist, and hospital services. Comparable as the broader corporate umbrella within which Dextra sits, providing booking infrastructure, certification, and catchment in Lahti, Kouvola, and Lappeenranna.
• CooperSurgical: Large US-headquartered fertility and reproductive medicine company providing IVF media, devices, genetic testing, and clinical services globally. Comparable to Dextra as a participant in the fertility treatment ecosystem, but as a multinational vendor rather than a Finnish clinic competitor.
• Mehiläinen: One of Finland's largest private healthcare providers, operating hospitals, clinics, and occupational health, with Felicitas as its fertility arm. Comparable to Dextra as a broader incumbent providing fertility services inside a wider healthcare portfolio.

Direct peers

• Fertinova: Nordic fertility clinic group operating across Sweden and other Nordic countries offering IVF, ICSI, and egg/sperm donation. Comparable to Dextra in service portfolio and is a natural peer if Dextra pursues cross-border Nordic expansion.
• Ovumia: Finnish fertility clinic group operating multiple sites across Finland offering IVF, ICSI, fertility investigations, and egg/sperm donation. Directly comparable to Dextra in services, geography, and customer profile, competing for the same Finnish private-pay patients.
• AVA Clinic: Tampere-based Finnish fertility clinic providing IVF, ICSI, PGT, and donor gamete services. Comparable to Dextra as a domestic specialist clinic; benefits from a different regional catchment, providing partial overlap rather than head-to-head competition in Helsinki.
• Felicitas Mehiläinen: Finnish fertility clinic brand within the Mehiläinen healthcare group, offering IVF, ICSI, donor treatments, and fertility investigations. Directly comparable as a domestic private fertility provider competing in the same customer and payer dynamics as Dextra.

Regional players

• Nordic IVF: Swedish fertility clinic network offering IVF, ICSI, and egg donation with a comparable private-clinic service model. Comparable to Dextra in service breadth and customer profile but operating primarily in Sweden rather than in Finland.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@hedelmallisyysklinikka
• Facebookfacebook.com/dextrahedelmallisyysklinikka
• Instagraminstagram.com/dextra_hedelmallisyysklinikka
• LinkedInlinkedin.com/company/dextra-fertility-clinic

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dextra Hedelmällisyysklinikka